Company intelligence / Profile preview
Daewoong Pharmaceutical
Seoul, Seoul, South Koreacrm.daewoong.co.kr ↗
- Ownership
- Public · 069620
- Employees
- ~1250
- Development stage
- Commercial
01
Overview
Daewoong Pharmaceutical is a leading South Korean pharmaceutical company with global operations. It has successfully developed and commercialized novel drugs such as Fexuprazan for GERD and Enavogliflozin for type 2 diabetes. Its pipeline includes innovative biologics like the CLOPAM® microneedle patch in Phase 1 trials and Bersiporocin—a first-in-class oral anti-fibrotic agent with FDA orphan drug status—in Phase 2 trials. The company also markets Nabota/Nuceiva botulinum toxin globally.
- Therapeutic areas
- PulmonologyEndocrinologyDermatologyRheumatologyNeurology
- Modalities
- Small moleculesBiologics (including biosimilars)Recombinant proteins (e.g., rh-EGF, rh-hGH, rh-BMP2)Botulinum toxin biologicsMicroneedle drug delivery systems
- Industry
- Biotech
02
Drug pipeline
110 assets109 more assets in the full pipeline.
Request access →03
Partnerships
Oncorus Inc. (joint research on mRNA anticancer drugs)Cooper Pharma Morocco (‘Fexuclue’ agreement)Consortium with Tionlab Therapeutics & Dalim Biotech on long‑acting obesity injection developmentKorea Chemical Bank collaboration on compound library research
Beyond the preview
Go deeper on Daewoong Pharmaceutical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Daewoong Pharmaceutical.